Celadon Pharmaceuticals Plc

  • Market Cap: N/A
  • Industry: Other Agricultural Products
  • ISIN: GB00BDQYGP38
GBP
0.13
0.02 (16.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

126.05 k

Shareholding (Dec 2021)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

GBP 9 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-215.27%

stock-summary
Price to Book

3.80

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
67.5%
0%
67.5%
6 Months
-10.67%
0%
-10.67%
1 Year
-83.04%
0%
-83.04%
2 Years
-91.01%
0%
-91.01%
3 Years
-85.97%
0%
-85.97%
4 Years
-92.76%
0%
-92.76%
5 Years
-85.51%
0%
-85.51%

Celadon Pharmaceuticals Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.10%
EBIT Growth (5y)
-242.99%
EBIT to Interest (avg)
-3.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.02
Tax Ratio
4.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.27
EV to EBIT
-0.59
EV to EBITDA
-0.66
EV to Capital Employed
1.27
EV to Sales
3.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-213.95%
ROE (Latest)
-215.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2021stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Celadon Pharmaceuticals Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.20",
          "val2": "-0.50",
          "chgp": "-2,340.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.40",
          "val2": "-0.50",
          "chgp": "-3,380.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-528,702.70%",
          "val2": "0.00%",
          "chgp": "-52,870.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-12.20
-0.50
-2,340.00%
Interest
4.00
0.00
Exceptional Items
-2.00
-0.00
Consolidate Net Profit
-17.40
-0.50
-3,380.00%
Operating Profit Margin (Excl OI)
-528,702.70%
0.00%
-52,870.27%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Celadon Pharmaceuticals Plc stock-summary
stock-summary
Celadon Pharmaceuticals Plc
Other Agricultural Products
Summerway Capital PLC is a United Kingdom-based company is focused on acquiring businesses. The Company invests in household and consumer goods sectors including retail and consumer brands, and targets acquisitions.
Company Coordinates stock-summary
Company Details
Fleetworks, 26 Farringdon Street , London None : EC4A 4AB
Registrar Details